Advertisement

Keryx Biopharmaceuticals, Inc. KERX

Set alert

Price alert · KERX

All alert types
3.36 0.00 0.00%

At close · Jun 28

3.36 Day range 3.36
2.47 52-week range 5.98
Open
3.36
Prev close
3.36
Mkt cap
0
Vol
0
Avg vol
1.13M
EPS
-0.75775
P/E
-4.43
More statistics
Low
3.36
High
3.36
Earnings
Feb 6, 2019

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for KERX has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue by
Auryxia → Revenue: $26.59MRevenue → Gross Profit: $19.66MGross Profit → Expenses: $19.66MRevenue → Cost of Revenue: $8.37MExpenses → Selling, General & Admin: $26.45MExpenses → Research & Development: $7.90MExpenses → Interest Expense: $144.00KExpenses → Other Expenses: $2.17MExpenses → Income Tax: $114.00KNet Loss → Expenses: $17.11MLicense → Revenue: $1.45MGross Profit$19.66MNet Loss$17.11MCost of Revenue$8.37MExpenses$36.77MSelling, General & Admin$26.45MResearch & Development$7.90MInterest Expense$144.00KOther Expenses$2.17MIncome Tax$114.00KRevenue$28.04MAuryxia$26.59MLicense$1.45M

Period ending Sep 30, 2018 · select a line to chart its history

Income statement

KERX quarterly income statement
28.04M
28.04M
7.51M
20.53M
35.22M
7.90M
26.45M
-14.69M
-17.00M
-17.00M
-17.00M
-17.00M
-0.14
-0.14
-0.14
-17.00M
-17.00M
120.43M
120.43M

Balance sheet

KERX quarterly balance sheet
41.15M
41.15M
14.61M
126.41M
3.85M
151.78M
147.30M
57.10M
147.30M
206.00M
-1.06B
-54.22M
-54.22M
25.37M
147.30M
3.21M
58.74M
148.90M
56.69M

Cash flow

KERX quarterly cash flow
251.00K
15.07M
-8.31M
73.00K
15.00M
-23.39M
3.86M
Advertisement